Jazz Pharmaceuticals

NASDAQ: JAZZ · Real-Time Price · USD
119.05
-0.15 (-0.13%)
At close: Aug 20, 2025, 3:37 PM
119.07
0.02%
After-hours: Aug 20, 2025, 04:04 PM EDT

Jazz Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-718.47M -92.54M 191.12M 215.06M 168.57M -14.62M 94.15M 146.82M 104.44M 69.42M -240.72M -19.65M 34.66M 1.65M -35.35M -52.83M -363.32M 121.83M
Depreciation & Amortization
174.01M 164.87M 168.42M 165.23M 163.03M 163.38M 159.2M 162.56M 159.58M 157.36M 144.73M 148.83M 156.2M 179.71M 164.62M 167.58M 147.31M 72.97M
Stock-Based Compensation
64.5M 67.65M 70.19M 59.76M 56.65M 61.44M 52.94M 56.12M 61.43M 56.35M 61.56M 56.68M 53.69M 50.07M 53.12M 53.24M 48.16M 34.48M
Other Working Capital
-238.34M 238.34M -59M n/a -46.23M 97.28M -96.04M -11M -3.55M -38.16M 119.69M 58.92M -524K 21.46M -43.02M 56.79M -16.39M 39.25M
Other Non-Cash Items
923.14M 45.73M 51.15M 52.7M 45.08M 67.01M 77.95M 45.17M 67.86M 85.31M 462.96M 226.98M 128.61M 63.58M 107.68M 122.03M 91.19M 24.54M
Deferred Income Tax
-66.42M -43.83M -2.35M -64.4M -75.18M -66.39M -35.9M -78.92M -79.33M -66.06M -145.38M -64.56M -36.98M -45.34M -27.39M -74.99M 190.7M -19.11M
Change in Working Capital
-287.9M 287.9M -79.93M -29.59M -26.81M 56.4M -181.01M -24.55M -17.21M 18.32M 58.83M 69.71M -77.94M -40.69M -84.92M 59.04M -72.35M 50.28M
Operating Cash Flow
88.86M 429.78M 398.58M 398.75M 331.35M 267.23M 167.34M 307.19M 296.76M 320.71M 341.97M 417.99M 303.04M 208.98M 177.75M 274.06M 41.7M 285M
Capital Expenditures
12.03M -38.88M -13.29M -10.79M -7.09M -6.9M -10.1M -4.3M -5.74M -4.82M -384.38M 4.9M -81.43M -37.29M -9.97M -26.22M -7.18M -2.17M
Cash Acquisitions
-858.05M n/a n/a n/a n/a n/a 20M -20M n/a n/a n/a n/a 53M n/a -6.23B n/a -6.23B 20.7M
Purchase of Investments
440.05M -440.05M -470M 705M -330M -375M -120.1M -190M -80M n/a 61.04M -300K -60.74M n/a -125K -594K -5.4M -20.7M
Sales Maturities Of Investments
470M 310M 290M 355M 80M 120M 250M 20M n/a n/a 60M n/a n/a n/a 26.82M n/a 335M 760M
Other Investing Acitivies
-680.05M -25M n/a -835.13M n/a -10M -38M 20M -80M -1M -61.04M -300K -76.88M -25M 6.21B -18.48M -6.23B -20.7M
Investing Cash Flow
-641.02M -168.93M -193.29M 214.09M -257.09M -271.9M 101.8M -174.3M -85.74M -4.82M -324.38M 4.6M -89.16M -37.29M -10.09M -26.81M -5.91B 737.13M
Debt Repayment
n/a -757.75M -7.75M 398.02M -7.75M -7.75M -7.75M -7.75M -7.75M -7.75M -7.75M -307.75M -7.75M -258.76M -258.76M -477.57M 4.62B -8.35M
Common Stock Repurchased
n/a n/a 360.73M -150M -161.43M -49.3M -99.8M -74.37M -95.59M -43.27M -2.81M -2.57M -6.34M -33.78M -6M -2.43M -3.39M -23.78M
Dividend Paid
n/a n/a n/a n/a n/a n/a -112.28M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
633.23M -55.72M -301.01M 396.43M -2.85M -48.8M 110.67M 3.63M -4.19M -22.04M 27.35M 18.69M 18.53M -12.05M 12.15M 12.39M 48.49M 26.62M
Financial Cash Flow
-124.53M -813.47M -8.28M 246.43M -161.09M -56.55M -100.31M -78.49M -96.67M -29.79M 19.6M -289.05M 10.78M -270.81M -246.61M -465.18M 4.66B 18.28M
Net Cash Flow
-672.07M -550.92M 194.73M 862.33M -87.58M -62.92M 170.62M 53.39M 114.39M 286.43M 42.12M 128.09M 220.43M -100.61M -80.33M -219.62M -1.21B 1.04B
Free Cash Flow
100.89M 390.9M 385.29M 387.96M 324.26M 260.32M 157.24M 302.9M 291.03M 315.89M -42.41M 422.89M 221.61M 171.69M 167.79M 247.84M 34.52M 282.83M